Gland Pharma Limited Gland Pharma Limited

Gland Pharma Limited

GLAND

株式のランク #3303
Gland Pharma Limited, established in Hyderabad, India, in 1978, is a... Gland Pharma Limited, established in Hyderabad, India, in 1978, is a pharmaceutical company that specializes in the creation, production, and global distribution of generic injectable medications. Its product line features key active pharmaceutical ingredients such as heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, among others. The company's extensive therapeutic portfolio encompasses anti-infectives, anesthetics, anticoagulants, antimalarials, cardiovascular drugs, gastrointestinal treatments, pain management, hormones, fertility aids, anti-cancer agents, gynecological remedies, neurological and central nervous system medications, respiratory treatments, blood-related products, ophthalmological and otological solutions, orthopedics, hematinics, and various vitamins, minerals, and nutrients. Additionally, Gland Pharma provides contract development services. The company primarily operates on a business-to-business (B2B) model, distributing its products across major markets including the United States, Europe, Canada, Australia, India, and other international territories. Gland Pharma Limited functions as a subsidiary of Fosun Pharma Industrial Pte. Ltd.
株価
$32.32
時価総額
$5.33B
変化(1日)
-3.01%
変化(1年)
47.99%
国
IN
取引 Gland Pharma Limited (GLAND)

カテゴリー

Healthcare
Gland Pharma Limited(GLAND)のP/B比率
October 2026 時点のP/B比率 TTM: 4.84
Gland Pharma Limited の最新の財務報告および株価によると、現在のP/B比率(TTM)は 4.84 です。2024 年末時点でのP/B比率は 3.43 でした。
Gland Pharma Limited の P/B 比率の履歴(2017 ~ 2026)
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) 4.84 72.92%
2025 2.80 -18.34%
2024 3.43 30.55%
2023 2.62 -65.05%
2022 7.51 13.10%
2021 6.64 -14.17%
2020 7.73 -25.51%
2019 10.38 -15.78%
2018 12.33 -8.64%
2017 13.49 0.00%